Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 120

1.

Angiotensin converting enzymes ACE and ACE2 in thyroid cancer progression.

Narayan SS, Lorenz K, Ukkat J, Hoang-Vu C, Trojanowicz B.

Neoplasma. 2019 Dec 17. pii: 190506N405. doi: 10.4149/neo_2019_190506N405. [Epub ahead of print]

PMID:
31847529
2.

Corrigendum to "Epidermal Growth Factor Cytoplasmic Domain Affects ErbB Protein Degradation by the Lysosomal and Ubiquitin-Proteasome Pathway in Human Cancer Cells" [Neoplasia 14 (2012) 396-409].

Glogowska A, Stetefeld J, Weber E, Ghavami S, Hoang-Vu C, Klonisch T.

Neoplasia. 2017 Apr;19(4):383. doi: 10.1016/j.neo.2017.01.009. No abstract available.

3.

Phosphatidylinositide 3-kinase (PI3K) and PI3K-related kinase (PIKK) activity contributes to radioresistance in thyroid carcinomas.

Burrows N, Williams J, Telfer BA, Resch J, Valentine HR, Fitzmaurice RJ, Eustace A, Irlam J, Rowling EJ, Hoang-Vu C, West CM, Brabant G, Williams KJ.

Oncotarget. 2016 Sep 27;7(39):63106-63123. doi: 10.18632/oncotarget.11056.

4.

Expression of ARE-binding proteins AUF1 and HuR in follicular adenoma and carcinoma of thyroid gland.

Trojanowicz B, Sekulla C, Dralle H, Hoang-Vu C.

Neoplasma. 2016;63(3):371-7. doi: 10.4149/305_150819N450.

PMID:
26925783
5.

RXFP1 is Targeted by Complement C1q Tumor Necrosis Factor-Related Factor 8 in Brain Cancer.

Thanasupawat T, Glogowska A, Burg M, Wong GW, Hoang-Vu C, Hombach-Klonisch S, Klonisch T.

Front Endocrinol (Lausanne). 2015 Aug 13;6:127. doi: 10.3389/fendo.2015.00127. eCollection 2015. Review.

6.

Phosphorylation of pyruvate kinase M2 and lactate dehydrogenase A by fibroblast growth factor receptor 1 in benign and malignant thyroid tissue.

Kachel P, Trojanowicz B, Sekulla C, Prenzel H, Dralle H, Hoang-Vu C.

BMC Cancer. 2015 Mar 18;15:140. doi: 10.1186/s12885-015-1135-y.

7.

RAGE Mediates the Pro-Migratory Response of Extracellular S100A4 in Human Thyroid Cancer Cells.

Medapati MR, Dahlmann M, Ghavami S, Pathak KA, Lucman L, Klonisch T, Hoang-Vu C, Stein U, Hombach-Klonisch S.

Thyroid. 2015 May;25(5):514-27. doi: 10.1089/thy.2014.0257. Epub 2015 Apr 3.

PMID:
25744544
8.

Expression of the IGF-1, IGFBP-3 and IGF-1 receptors in dental pulp stem cells and impacted third molars.

Magnucki G, Schenk U, Ahrens S, Navarrete Santos A, Gernhardt CR, Schaller HG, Hoang-Vu C.

J Oral Sci. 2013;55(4):319-27.

9.

C1q-tumour necrosis factor-related protein 8 (CTRP8) is a novel interaction partner of relaxin receptor RXFP1 in human brain cancer cells.

Glogowska A, Kunanuvat U, Stetefeld J, Patel TR, Thanasupawat T, Krcek J, Weber E, Wong GW, Del Bigio MR, Hoang-Vu C, Hombach-Klonisch S, Klonisch T.

J Pathol. 2013 Dec;231(4):466-79. doi: 10.1002/path.4257.

PMID:
24014093
10.

Short hairpin RNA targeting autotaxin reduces human gastric carcinoma AGS cell proliferative, migratory and invasive capabilities in vitro and causes tumor regression in vivo.

Chen Z, Huang Y, Shen X, Guo J, Zhu G, Dralle H, Hoang-Vu C.

Oncol Rep. 2013 Mar;29(3):1087-93. doi: 10.3892/or.2012.2204. Epub 2012 Dec 20.

PMID:
23258351
11.

Role of glutaminyl cyclases in thyroid carcinomas.

Kehlen A, Haegele M, Menge K, Gans K, Immel UD, Hoang-Vu C, Klonisch T, Demuth HU.

Endocr Relat Cancer. 2013 Feb 18;20(1):79-90. doi: 10.1530/ERC-12-0053. Print 2013 Feb.

PMID:
23183267
12.

INSL5 is a novel marker for human enteroendocrine cells of the large intestine and neuroendocrine tumours.

Thanasupawat T, Hammje K, Adham I, Ghia JE, Del Bigio MR, Krcek J, Hoang-Vu C, Klonisch T, Hombach-Klonisch S.

Oncol Rep. 2013 Jan;29(1):149-54. doi: 10.3892/or.2012.2119. Epub 2012 Oct 31.

PMID:
23128569
13.

Targeting of the anti-apoptotic gene survivin in human thyroid carcinoma.

Chen Z, Liu N, Zhu G, Dralle H, Hoang-Vu C.

Int J Mol Med. 2012 Sep;30(3):465-72. doi: 10.3892/ijmm.2012.1046. Epub 2012 Jun 28.

14.
15.

AUF1 and HuR: possible implications of mRNA stability in thyroid function and disorders.

Trojanowicz B, Dralle H, Hoang-Vu C.

Thyroid Res. 2011 Aug 3;4 Suppl 1:S5. doi: 10.1186/1756-6614-4-S1-S5.

16.

Down-regulation of TM4SF is associated with the metastatic potential of gastric carcinoma TM4SF members in gastric carcinoma.

Chen Z, Gu S, Trojanowicz B, Liu N, Zhu G, Dralle H, Hoang-Vu C.

World J Surg Oncol. 2011 Apr 27;9:43. doi: 10.1186/1477-7819-9-43.

17.

Relaxin enhances the collagenolytic activity and in vitro invasiveness by upregulating matrix metalloproteinases in human thyroid carcinoma cells.

Bialek J, Kunanuvat U, Hombach-Klonisch S, Spens A, Stetefeld J, Sunley K, Lippert D, Wilkins JA, Hoang-Vu C, Klonisch T.

Mol Cancer Res. 2011 Jun;9(6):673-87. doi: 10.1158/1541-7786.MCR-10-0411. Epub 2011 Apr 14.

18.

Biomarkers in thyroid tumor research: new diagnostic tools and potential targets of molecular-based therapy.

Gimm O, Castellone MD, Hoang-Vu C, Kebebew E.

J Thyroid Res. 2011;2011:631593. doi: 10.4061/2011/631593. Epub 2012 Feb 16. No abstract available.

19.

Proteomic approach reveals novel targets for retinoic acid-mediated therapy of thyroid carcinoma.

Trojanowicz B, Sekulla C, Lorenz K, Köhrle J, Finke R, Dralle H, Hoang-Vu C.

Mol Cell Endocrinol. 2010 Aug 30;325(1-2):110-7. doi: 10.1016/j.mce.2010.05.022. Epub 2010 Jun 9.

PMID:
20538039
20.

Downregulation of microRNAs directs the EMT and invasive potential of anaplastic thyroid carcinomas.

Braun J, Hoang-Vu C, Dralle H, Hüttelmaier S.

Oncogene. 2010 Jul 22;29(29):4237-44. doi: 10.1038/onc.2010.169. Epub 2010 May 24.

PMID:
20498632
21.

Role of CD97 isoforms in gastric carcinoma.

Liu D, Trojanowicz B, Radestock Y, Fu T, Hammje K, Chen L, Hoang-Vu C.

Int J Oncol. 2010 Jun;36(6):1401-8.

PMID:
20428763
22.

Relaxin enhances S100A4 and promotes growth of human thyroid carcinoma cell xenografts.

Radestock Y, Willing C, Kehlen A, Hoang-Vu C, Hombach-Klonisch S.

Mol Cancer Res. 2010 Apr;8(4):494-506. doi: 10.1158/1541-7786.MCR-09-0307. Epub 2010 Mar 23.

23.

Thyroid stem cells and cancer.

Klonisch T, Hoang-Vu C, Hombach-Klonisch S.

Thyroid. 2009 Dec;19(12):1303-15. doi: 10.1089/thy.2009.1604. Review.

PMID:
20001714
24.

INSL3 has tumor-promoting activity in thyroid cancer.

Hombach-Klonisch S, Bialek J, Radestock Y, Truong A, Agoulnik AI, Fiebig B, Willing C, Weber E, Hoang-Vu C, Klonisch T.

Int J Cancer. 2010 Aug 1;127(3):521-31. doi: 10.1002/ijc.25068.

25.

EGFR ligands exert diverging effects on male reproductive organs.

Schneider MR, Gratao AA, Dahlhoff M, Boersma A, Hrabé de Angelis M, Hoang-Vu C, Wolf E, Klonisch T.

Exp Mol Pathol. 2010 Feb;88(1):216-8. doi: 10.1016/j.yexmp.2009.11.005. Epub 2009 Nov 25.

PMID:
19931240
26.

Expression of hypoxia-inducible factor 1 alpha in thyroid carcinomas.

Burrows N, Resch J, Cowen RL, von Wasielewski R, Hoang-Vu C, West CM, Williams KJ, Brabant G.

Endocr Relat Cancer. 2010 Jan 29;17(1):61-72. doi: 10.1677/ERC-08-0251. Print 2010 Mar.

27.

The role of AUF1 in thyroid carcinoma progression.

Trojanowicz B, Brodauf L, Sekulla C, Lorenz K, Finke R, Dralle H, Hoang-Vu C.

Endocr Relat Cancer. 2009 Sep;16(3):857-71. doi: 10.1677/ERC-08-0234. Epub 2009 Jul 2.

PMID:
19574297
28.

Lysosomal acid hydrolases of the cathepsin family are novel targets of INSL3 in human thyroid carcinoma cells.

Bialek J, Hombach-Klonisch S, Fiebig B, Weber E, Hoang-Vu C, Klonisch T.

Ann N Y Acad Sci. 2009 Apr;1160:361-6. doi: 10.1111/j.1749-6632.2009.03832.x.

PMID:
19416220
29.

Retinoic acid-mediated down-regulation of ENO1/MBP-1 gene products caused decreased invasiveness of the follicular thyroid carcinoma cell lines.

Trojanowicz B, Winkler A, Hammje K, Chen Z, Sekulla C, Glanz D, Schmutzler C, Mentrup B, Hombach-Klonisch S, Klonisch T, Finke R, Köhrle J, Dralle H, Hoang-Vu C.

J Mol Endocrinol. 2009 Mar;42(3):249-60. doi: 10.1677/JME-08-0118. Epub 2008 Dec 5.

PMID:
19060179
30.

Expression of the Grb2-related RET adapter protein Grap-2 in human medullary thyroid carcinoma.

Ludwig L, Oswald F, Hoang-Vu C, Dralle H, Hildt E, Schmid RM, Karges W.

Cancer Lett. 2009 Mar 18;275(2):194-7. doi: 10.1016/j.canlet.2008.10.010. Epub 2008 Nov 21.

PMID:
19027225
31.

The cytoplasmic domain of proEGF negatively regulates motility and elastinolytic activity in thyroid carcinoma cells.

Glogowska A, Pyka J, Kehlen A, Los M, Perumal P, Weber E, Cheng SY, Hoang-Vu C, Klonisch T.

Neoplasia. 2008 Oct;10(10):1120-30.

32.

Relaxin reduces xenograft tumour growth of human MDA-MB-231 breast cancer cells.

Radestock Y, Hoang-Vu C, Hombach-Klonisch S.

Breast Cancer Res. 2008;10(4):R71. doi: 10.1186/bcr2136. Epub 2008 Aug 21.

33.

Cancer stem cells as targets for cancer therapy: selected cancers as examples.

Hombach-Klonisch S, Paranjothy T, Wiechec E, Pocar P, Mustafa T, Seifert A, Zahl C, Gerlach KL, Biermann K, Steger K, Hoang-Vu C, Schulze-Osthoff K, Los M.

Arch Immunol Ther Exp (Warsz). 2008 May-Jun;56(3):165-80. doi: 10.1007/s00005-008-0023-4. Epub 2008 May 30. Review.

34.

The cellular localization of autotaxin impacts on its biological functions in human thyroid carcinoma cells.

Seifert A, Klonisch T, Wulfaenger J, Haag F, Dralle H, Langner J, Hoang-Vu C, Kehlen A.

Oncol Rep. 2008 Jun;19(6):1485-91.

PMID:
18497954
35.

Relaxin-like ligand-receptor systems are autocrine/paracrine effectors in tumor cells and modulate cancer progression and tissue invasiveness.

Klonisch T, Bialek J, Radestock Y, Hoang-Vu C, Hombach-Klonisch S.

Adv Exp Med Biol. 2007;612:104-18. Review.

PMID:
18161484
36.

Selenoproteins of the thyroid gland: expression, localization and possible function of glutathione peroxidase 3.

Schmutzler C, Mentrup B, Schomburg L, Hoang-Vu C, Herzog V, Köhrle J.

Biol Chem. 2007 Oct;388(10):1053-9.

PMID:
17937619
37.

The ultraviolet filter benzophenone 2 interferes with the thyroid hormone axis in rats and is a potent in vitro inhibitor of human recombinant thyroid peroxidase.

Schmutzler C, Bacinski A, Gotthardt I, Huhne K, Ambrugger P, Klammer H, Schlecht C, Hoang-Vu C, Grüters A, Wuttke W, Jarry H, Köhrle J.

Endocrinology. 2007 Jun;148(6):2835-44. Epub 2007 Mar 22.

PMID:
17379648
38.

Expression of neutral endopeptidase (NEP/CD10) on pancreatic tumor cell lines, pancreatitis and pancreatic tumor tissues.

Erhuma M, Köbel M, Mustafa T, Wulfänger J, Dralle H, Hoang-Vu C, Langner J, Seliger B, Kehlen A.

Int J Cancer. 2007 Jun 1;120(11):2393-400.

39.

Distinct expression of galectin-3 in pheochromocytomas.

Gimm O, Krause U, Brauckhoff M, Hoang-Vu C, Dralle H.

Ann N Y Acad Sci. 2006 Aug;1073:571-7.

PMID:
17102125
40.

[Role of the class II tumor suppressor gene maspin in thyroid carcinogenesis].

Boltze C, Hoang-Vu C, Schneider-Stock R, Lehnert H, Roessner A.

Verh Dtsch Ges Pathol. 2004;88:237-45. German.

PMID:
16892558
41.

CpG island methylation of tumor-related promoters occurs preferentially in undifferentiated carcinoma.

Schagdarsurengin U, Gimm O, Dralle H, Hoang-Vu C, Dammann R.

Thyroid. 2006 Jul;16(7):633-42.

PMID:
16889486
42.

Relaxin enhances the oncogenic potential of human thyroid carcinoma cells.

Hombach-Klonisch S, Bialek J, Trojanowicz B, Weber E, Holzhausen HJ, Silvertown JD, Summerlee AJ, Dralle H, Hoang-Vu C, Klonisch T.

Am J Pathol. 2006 Aug;169(2):617-32.

43.

Fetal microchimerism in Hashimoto's thyroiditis: a quantitative approach.

Klintschar M, Immel UD, Kehlen A, Schwaiger P, Mustafa T, Mannweiler S, Regauer S, Kleiber M, Hoang-Vu C.

Eur J Endocrinol. 2006 Feb;154(2):237-41.

PMID:
16452536
44.

AhR-agonist-induced transcriptional changes of genes involved in thyroid function in primary porcine thyrocytes.

Pocar P, Klonisch T, Brandsch C, Eder K, Fröhlich C, Hoang-Vu C, Hombach-Klonisch S.

Toxicol Sci. 2006 Feb;89(2):408-14. Epub 2005 Nov 16.

PMID:
16291828
45.

The expression of CD97EGF and its ligand CD55 on marginal epithelium is related to higher stage and depth of tumor invasion of gastric carcinomas.

Liu Y, Chen L, Peng S, Chen Z, Gimm O, Finke R, Hoang-Vu C.

Oncol Rep. 2005 Dec;14(6):1413-20.

PMID:
16273233
46.

Role of CD97(stalk) and CD55 as molecular markers for prognosis and therapy of gastric carcinoma patients.

Liu Y, Chen L, Peng SY, Chen ZX, Hoang-Vu C.

J Zhejiang Univ Sci B. 2005 Sep;6(9):913-8.

47.

INSL3 in the benign hyperplastic and neoplastic human prostate gland.

Klonisch T, Müller-Huesmann H, Riedel M, Kehlen A, Bialek J, Radestock Y, Holzhausen HJ, Steger K, Ludwig M, Weidner W, Hoang-Vu C, Hombach-Klonisch S.

Int J Oncol. 2005 Aug;27(2):307-15.

PMID:
16010410
48.

Relaxin downregulates the calcium binding protein S100A4 in MDA-MB-231 human breast cancer cells.

Radestock Y, Hoang-Vu C, Hombach-Klonisch S.

Ann N Y Acad Sci. 2005 May;1041:462-9.

PMID:
15956747
49.

Human medullary thyroid carcinoma: a source and potential target for relaxin-like hormones.

Klonisch T, Mustafa T, Bialek J, Radestock Y, Holzhausen HJ, Dralle H, Hoang-Vu C, Hombach-Klonisch S.

Ann N Y Acad Sci. 2005 May;1041:449-61.

PMID:
15956746
50.

Selenoprotein expression in Hürthle cell carcinomas and in the human Hürthle cell carcinoma line XTC.UC1.

Menth M, Schmutzler C, Mentrup B, Hoang-Vu C, Takahashi K, Honjoh T, Köhrle J.

Thyroid. 2005 May;15(5):405-16.

PMID:
15929660

Supplemental Content

Loading ...
Support Center